Skip to main content

Advertisement

SpringerLink
Log in

Secondary resistance to tolvaptan in two patients with SIAD due to small cell lung cancer

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS et al (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355(20):2099–2112

    Article  CAS  PubMed  Google Scholar 

  2. Salahudeen AK, Ali N, George M, Lahoti A, Palla S (2014) Tolvaptan in hospitalized cancer patients with hyponatremia: a double-blind, randomized, placebo-controlled clinical trial on efficacy and safety. Cancer 120(5):744–751

    Article  CAS  PubMed  Google Scholar 

  3. Berl T, Quittnat-Pelletier F, Verbalis JG, Schrier RW, Bichet DG, Ouyang J et al (2010) Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol 21(4):705–712

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Dr. Chris Boot (Newcastle upon Tyne) for the measurement of plasma copeptin.

Author information

Authors and Affiliations

  1. Academic Department of Endocrinology, Beaumont Hospital and RCSI Medical School, Dublin, Ireland

    A. Garrahy, A. M. Hannon, H. M. Zia-Ul-Hussnain & C. J. Thompson

  2. Department of Geriatric and Stroke Medicine, Beaumont Hospital and RCSI Medical School, Dublin, Ireland

    D. J. Williams

Authors
  1. A. Garrahy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. M. Hannon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. M. Zia-Ul-Hussnain
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. J. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. J. Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Garrahy.

Ethics declarations

Conflict of interest

Professor Chris Thompson has received honoraria for lectures from Otsuka.

Dr. Aoife Garrahy, Dr. Anne Marie Hannon, Dr. Zia-Ul-Hussnain, and Professor David Williams have no potential conflicts of interest.

Electronic supplementary material

ESM 1

(DOCX 46 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garrahy, A., Hannon, A.M., Zia-Ul-Hussnain, H.M. et al. Secondary resistance to tolvaptan in two patients with SIAD due to small cell lung cancer. Eur J Clin Pharmacol 74, 245–246 (2018). https://doi.org/10.1007/s00228-017-2363-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-017-2363-7

Search

Navigation